HomeIONS • NASDAQ
add
Ionis Pharmaceuticals Inc
Previous close
$32.22
Day range
$31.46 - $32.97
Year range
$30.23 - $52.34
Market cap
5.20B USD
Avg Volume
1.74M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 226.58M | -30.18% |
Operating expense | 88.08M | 72.67% |
Net income | -104.35M | -1,026.51% |
Net profit margin | -46.05 | -1,515.79% |
Earnings per share | -0.43 | -464.44% |
EBITDA | -108.12M | -733.19% |
Effective tax rate | 2.51% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.30B | -1.48% |
Total assets | 3.00B | 0.45% |
Total liabilities | 2.42B | -7.22% |
Total equity | 588.35M | — |
Shares outstanding | 158.96M | — |
Price to book | 8.64 | — |
Return on assets | -9.11% | — |
Return on capital | -10.65% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -104.35M | -1,026.51% |
Cash from operations | -116.14M | -453.38% |
Cash from investing | 68.21M | 355.36% |
Cash from financing | -44.12M | -208.33% |
Net change in cash | -92.53M | -296.01% |
Free cash flow | -113.03M | -268.37% |
About
Ionis Pharmaceuticals, Inc. is a biotechnology company based in Carlsbad, California, that specializes in discovering and developing RNA-targeted therapeutics. The company has three commercially approved medicines: Spinraza, Tegsedi, and Waylivra, and has four drugs in pivotal studies: tominersen for Huntington's disease, tofersen for SOD1-ALS, AKCEA-APO-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis.
The company was named Isis Pharmaceuticals until December 2015. Wikipedia
Founded
1989
Headquarters
Website
Employees
1,069
